- Home
- HWH vs OSRH Comparison
HWH vs OSRH Comparison
Compare HWH & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWH
- OSRH
- Stock Information
- Founded
- HWH 2021
- OSRH N/A
- Country
- HWH United States
- OSRH United States
- Employees
- HWH N/A
- OSRH N/A
- Industry
- HWH Other Pharmaceuticals
- OSRH
- Sector
- HWH Health Care
- OSRH
- Exchange
- HWH Nasdaq
- OSRH Nasdaq
- Market Cap
- HWH 10.1M
- OSRH 11.1M
- IPO Year
- HWH N/A
- OSRH N/A
- Fundamental
- Price
- HWH $4.72
- OSRH $0.72
- Analyst Decision
- HWH
- OSRH
- Analyst Count
- HWH 0
- OSRH 0
- Target Price
- HWH N/A
- OSRH N/A
- AVG Volume (30 Days)
- HWH 15.7M
- OSRH 13.8M
- Earning Date
- HWH 08-14-2025
- OSRH 08-14-2025
- Dividend Yield
- HWH N/A
- OSRH N/A
- EPS Growth
- HWH N/A
- OSRH N/A
- EPS
- HWH N/A
- OSRH N/A
- Revenue
- HWH $1,238,173.00
- OSRH $104,735.00
- Revenue This Year
- HWH N/A
- OSRH N/A
- Revenue Next Year
- HWH N/A
- OSRH N/A
- P/E Ratio
- HWH N/A
- OSRH N/A
- Revenue Growth
- HWH 17.28
- OSRH N/A
- 52 Week Low
- HWH $0.90
- OSRH $0.45
- 52 Week High
- HWH $7.77
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- HWH 90.46
- OSRH 47.84
- Support Level
- HWH $1.38
- OSRH $0.74
- Resistance Level
- HWH $1.47
- OSRH $1.24
- Average True Range (ATR)
- HWH 0.47
- OSRH 0.10
- MACD
- HWH 0.20
- OSRH 0.04
- Stochastic Oscillator
- HWH 52.71
- OSRH 34.46
About HWH HWH International Inc.
HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.